Effect of daidzein-low-calorie diet on body weight, serum levels of glucose, resistin, and high sensitive C-reactive protein in high fat, high calorie diet induced rats

Saudi Medical Journal

Volumn 33, Issue 1, 2012, Pages 70-75

  Mohamad Shahi, Majid ^a   Karandish, Majid ^a   Haidari, Fatemeh ^a   Omidian, Kosar ^a   Fatemi Tabatabayei, Seyed Reza ^a   Rafiei, Hossein ^a  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DAIDZEIN; GLUCOSE; RESISTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG SCREENING; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; LOW CALORY DIET; MALE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; C-REACTIVE PROTEIN; DIET; ENERGY INTAKE; ISOFLAVONES; RATS; RESISTIN;

EID: 84856701523     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33: 1078-1081.
2. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
3. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-476.
4. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331-335.
5. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 2006; 91: 1081-1086.
6. Mohammadzadeh G, Zarghami N, Mobaseri M. Serum resistin concentration in obese diabetic patients: any possible relation to insulin resistance indices? International Journal Endocrinology and Metabolism 2008; 6: 183-193.
7. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191-1201.
8. Manzoni MS, Rossi EA, Carlos IZ, Vendramini RC, Duarte AC, Dâmaso AR. Fermented soy product supplemented with isoflavones affected fat depots in juvenile rats. Nutrition 2005; 21: 1018-1024.
9. Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol 2009; 304: 30-42.
10. Hall WL, Vafeiadou K, Hallund J, Bügel S, Koebnick C, Reimann M, et al. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 2005; 82: 1260-1268.
11. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, et al. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003; 144: 3315-3320.
12. Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci 2006; 79: 1578-1584.
13. Sung MJ, Kim DH, Davaatseren M, Hur HJ, Kim W, Jung YJ, et al. Genistein suppression of TNF-alpha-induced fractalkine expression in endothelial cells. Cell Physiol Biochem 2010; 26: 431-440.
14. Guo Y, Wu G, Su X, Yang H, Zhang J. Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet. Nutr Res 2009; 29: 656-663.
15. Woods SC, Seeley RJ, Rushing PA, D'Alessio D, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr 2003; 133: 1081-1087.
16. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191-1201.
17. Lavigne C, Marette A, Jacques H. Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 2000; 278: E491-E500.
18. Nagasawa A, Fukui K, Kojima M, Kishida K, Maeda N, Nagaretani H, et al. Divergent effects of soy protein diet on the expression of adipocytokines. Biochem Biophys Res Commun 2003; 311: 909-914.
19. Raitakari M, Ilvonen T, Ahotupa M, Lehtimäki T, Harmoinen A, Suominen P, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 2004; 24: 124-128.
20. Wagner JD, Zhang L, Shadoan MK, Kavanagh K, Chen H, Tresnasari K, et al. Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys. Metabolism 2008; 57: S24-S31.
21. Chen SW, Zhang LS, Zhang HM, Feng XF. [Effects of soy isoflavone on levels of low-grade inflammatory peptides in rats with insulin resistance]. Nan Fang Yi Ke Da Xue Xue Bao 2006; 26: 1484-1486. Chinese.
22. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
23. Hotamisligil GS. The irresistible biology of resistin. J Clin Invest 2003; 111: 173-174.
24. Gómez-Ambrosi J, Frühbeck G. Do resistin and resistin-like molecules also link obesity to inflammatory diseases?. Ann Intern Med 2001; 135: 306-307.
25. Lee IS, Shin G, Choue R. Shifts in diet from high fat to high carbohydrate improved levels of adipokines and proinflammatory cytokines in mice fed a high-fat diet. Endocr J 2010; 57: 39-50.
26. Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K. The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 2008; 149: 2208-2218.
27. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114: 232-239.
28. Asensio C, Cettour-Rose P, Theander-Carrillo C, Rohner-Jeanrenaud F, Muzzin P. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/ type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology 2004; 145: 2206-2213.
29. O'Brien KD, Brehm BJ, Seeley RJ, Bean J, Wener MH, Daniels S, et al. Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 2005; 90: 2244-2249.
30. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007; 167: 31-39.
31. Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001; 21: 968-970.
32. Heilbronn LK, Clifton PM. C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. J Nutr Biochem 2002; 13: 316-321.
33. Jenkins DJ, Kendall CW, Connelly PW, Jackson CJ, Parker T, Faulkner D, et al. Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 2002; 51: 919-924.